Skip to main content

Advertisement

SpringerLink
Log in

Nanomedicine

An iron age for cancer therapy

  • News & Views
  • Published:

From Nature Nanotechnology

View current issue Submit your manuscript

Two reports show FDA-approved nanoparticles can kill cancer cells through iron- and reactive oxygen species-dependent mechanisms, offering new strategies for cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Engineered nanoparticles kill cancer cells by manipulating iron levels and causing an accumulation of reactive oxygen species.

References

  1. Torti, S. V. & Torti, F. M. Nat. Rev. Cancer 13, 342–355 (2013).

    Article  CAS  Google Scholar 

  2. Trachootham, D., Alexandre, J. & Huang, P. Nat. Rev. Drug Discov. 8, 579–591 (2009).

    Article  CAS  Google Scholar 

  3. Kim, S. E. et al. Nat. Nanotech. 11, 977–985(2016).

    Article  CAS  Google Scholar 

  4. Zanganeh, S. et al. Nat. Nanotech. 11, 986–994 (2016).

    Article  CAS  Google Scholar 

  5. Dixon, S. J. et al. Cell 149, 1060–1072 (2012).

    Article  CAS  Google Scholar 

  6. Gao, M. et al. Mol. Cell 59, 298–308 (2015).

    Article  CAS  Google Scholar 

  7. Qian, B. Z. & Pollard, J. W. Cell 141, 39–51 (2010).

    Article  CAS  Google Scholar 

  8. Sarosiek, K. A. et al. Mol. Cell 51, 751–765 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Amy Tarangelo and Scott J. Dixon are in the Program in Cancer Biology and the Department of Biology, Stanford University, Room 104, 337 Campus Drive, Stanford, California 94305, USA,

    Amy Tarangelo & Scott J. Dixon

Authors
  1. Amy Tarangelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott J. Dixon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott J. Dixon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tarangelo, A., Dixon, S. An iron age for cancer therapy. Nature Nanotech 11, 921–922 (2016). https://doi.org/10.1038/nnano.2016.199

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2016.199

  • Springer Nature Limited

This article is cited by

Search

Navigation